Strategy & Commercialisation
Maximize the commercial potential of your products and services as part of our focused managed portfolio. IMIP offer a fully tailored, practical solution to launching your state-of –the-art products.
Through leading edge science and technologies, IMIP are committed to helping physicians diagnose diseases faster, enabling appropriate therapy selection faster through the analysis of genetic material and proteins at the molecular level.
IMIP are committed to bringing high quality innovative products to the physicians, laboratory, and the patient in the areas of point of care, oncology, genetics and infectious disease.IMIP represents, markets and distributes both established and niche technologies across a number of diagnostic settings: – focused primarily on Molecular Diagnostics and Point of Care Diagnostic Technologies.